The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
Related posts:
Biden’s challenge: Creating enough tests and sequencing to track the virus
Moderna in talks with FDA to increase vaccine doses per vial
How the opioid epidemic is derailing Biden’s pick to fight the pandemic
Biden rolls back Trump’s anti-abortion curbs on family planning funds
Biden administration investing $1.7B to better track Covid-19 variants
Fauci: Pandemic exposed ‘undeniable effects of racism’
CDC remakes its Covid-19 response after criticism over mask guidelines
NIH director sees ‘no signs’ of a Delta peak
Biden administration to encourage boosters for most Americans
Moderna to ask FDA to authorize Covid-19 vaccine for young kids
Fauci: Expect yearly Covid boosters, barring ‘dramatically different variant’
HIV infections drop, but racial gaps remain
